Direxion Daily S&P Biotech Bear 3X ETF
Not enough financial coverage to compute a composite score for LABD. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.direxion.com/product/daily-sp-biotech-bull-bear-3x-etfs
The Direxion Daily S&P Biotech Bull and Bear 3X ETFs seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.
- IPO
- 2015
- HQ
- New York, DE, US
Price Chart
Valuation
- Market Cap
- $32.96M
- Div Yield
- 6.54%
Performance & Tape
- 52W High
- $90.60
- 52W Low
- $12.46
- 50D MA
- $15.86
- 200D MA
- $27.65
- Beta
- -3.15
- Avg Volume
- 5.23M
Get TickerSpark's AI analysis on LABD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our LABD Coverage
We haven't published any research on LABD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LABD Report →